The aim of this study was to investigate the frequency of alexithymia and attention deficit and to evaluate their relationship with the severity of disease in patients with fibromyalgia syndrome ...(FMS).
A total of 101 patients (6 males, 95 females; mean age 45.0 years; range, 33 to 56 years) who were admitted to Gaziantep University, Medical Faculty, Physical Medicine and Rehabilitation Department between January 2013 and December 2013 and were diagnosed with FMS and 40 healthy volunteers (4 males, 36 females; mean age 41.5 years; range, 31 to 51 years) were enrolled in this study. The Fibromyalgia Impact Questionnaire (FIQ), Hamilton Depression Scale (HAM-D), Toronto Alexithymia Scale-26 (TAS-26), and Jasper-Goldberg Attention Deficit Test (ADT) were applied.
The rate of alexithymia and possible alexithymia was 56.4% and 20.8% in the patients with FMS and 2.5% and 5% in the control group, respectively. The mean TAS-26 score was 60.1±11.7 in the patients with FMS. According to the HAM-D, depressive symptoms were seen in 72.0% and 2.5% of the patients with FMS and healthy controls, respectively.
Our study results confirm the presence of psychiatric comorbidities in patients with FMS and clearly suggest that depression, alexithymia, and attention deficit are high and mutually correlated in FMS patients. Therefore, all patients should be meticulously evaluated for these conditions at the treatment stage.
Earthquakes and their consequences present a major global public health problem. In 1998, a major earthquake struck Southern Turkey. The aims of this study were to describe longitudinally the ...severity and the course of posttraumatic stress disorder (PTSD) and depression among earthquake survivors in Turkey and to explore risk factors associated with psychiatric disorders. The sample of this study consists of 105 consecutive subjects who used our psychiatric service, via either outpatient clinic or home visit. PTSD was assessed by the Clinician-Administered PTSD Scale for
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. The severity of depression was assessed using Beck Depression Inventory. The rates of earthquake-related
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition PTSD were 42% within 1 month and 23% within 13 months. The diagnosis of PTSD was significantly related to the presence of injury and to less social support in the initial assessment. In the follow-up assessment, although the mean total Clinician-Administered PTSD Scale severity score improved significantly, the mean Beck Depression Inventory score did not change significantly. The decrease in posttraumatic stress symptoms 13 months after the earthquake may be related to relatively good living conditions and adequate social and health services. Early mental health intervention may serve to prevent the chronicity of posttraumatic stress reactions among earthquake victims.
Amaç: Bu çalışmanın amacı madde kullanım bozukluğu (MKB) tanılı hastalarda içselleştirilmiş damgalanma ile tedavi motivasyon ve hastaların klinik özellikleri arasındaki ilişkiyi araştırmaktır
Yöntem: ...Bu araştırma Haziran 2020-Aralık 2020 tarihleri arasında Gaziantep Üniversitesi psikiyatri servisinde madde kullanım bozukluğu tanısıyla takip ve tedavisi yapılan 63 katılımcıyı içermektedir. Araştırmanın verileri; sosyo-demografik veri ölçeği, içselleştirilmiş damgalanma ölçeği (RHİDÖ) ve tedavi motivasyonu anketi (TİM) kullanılarak toplanmıştır.
Bulgular: Korelasyon analizinde; RHİDÖ toplam ile TİM toplam arasında istatiksel olarak anlamlı bir ilişki saptanmadı. Hastaların madde başlama yaşı ile RHİDÖ algılanan ayrımcılık alt ölçeği arasında istatistiksel olarak anlamlı ve pozitif yönde bir ilişki bulundu. Self mutilasyonu olan hastaların RHİDÖ kalıp yargılar alt ölçeği self mutilasyonu olmayanlardan anlamlı oranda daha yüksekti. İntihar girişimi öyküsü olan hastaların RHİDÖ damgalanmaya direnç alt ölçeği puanı intihar girişimi olmayanlardan daha yüksekti. Hastaların yaşı, madde başlama yaşı, yatış sayısı, eğitim düzeyi, adli öyküsü, self mutilasyon, intihar öyküsü ve ailede madde kullanımı varlığı ile TİM ölçekleri arasında istatistiksel anlamlı ilişki bulunmadı.
Sonuç: Madde kullanım bozukluğu olan hastalarda, içselleştirilmiş damgalanmanın tedavi motivasyonu ile ilişkili olmadığı saptandı. RHİDÖ tüm alt ölçekleri ile birlikte incelendiğinde, madde başlama yaşının, self mutilasyonun ve geçmişte intihar girişimi bulunmasının içselleştirilmiş damgalamayı etkileyebileceği düşünüldü.
Objective: The aim of this study was to investigate the relationship of internalized stigmatization with treatment motivation and clinical characteristics of patients with substance use disorder (SUD).
Method: This research includes 63 participants who were followed up and treated with the diagnosis of substance use disorder in Gaziantep University psychiatry inpatient clinic between June 2020 and December 2020. The socio-demographic data, the scale of internalized stigma in mental illnesses
(ISMI) and the treatment motivation questionnaire (TIM) were used to assessment.
Results: In correlation analysis; There was no statistically significant relationship between ISMI total and TIM total. Perceived discrimination subscale of ISMI was significantly correlated with the age at onset of substance use. There was a significant differences between patients with and without selfmutilation in terms of stereotype endorsement subscale of the ISMI. There was a significant differences between patients with and without suicide attempt history in terms of stigma resistance subscale of the ISMI. There was no significant correlation between TIM and age at onset of substance use, the number of hospitalizations, the level of education, criminal history, self-mutilation, past suicide attempts, family history of substance use.
Conclusion: Although no significant relationship was found between internalized stigmatization and treatment motivation in patients with substance use disorder, it can be concluded that the age of substance onset, self-mutilation, and having history of suicide attempt may affect internalized
stigmatization when examined ISMI with the all subscales.
Several lines of evidence indicate that circadian rhythm disruption is associated with bipolar disorder (BPD). This strong association, along with evidence from genome wide association studies (GWAS) ...implicating clock and clock controlled genes with BDP and efficacy of lithium treatment, suggests that BPD circadian rhythm disruption may represent a core etiology feature. Lower morning expression of the neuropeptide somatostatin (SST) has been previously reported in the brain and cerebral spinal fluid of subjects with BPD, coinciding with increased morning severity of anxiety and depression. We aimed to test the hypothesis that levels of neuropeptides involved in circadian rhythm regulation, including somatostatin (SST), neuropeptide-Y (NPY), arginine vasopressin (AVP), vasoactive intestinal peptide (VIP) and cortisol levels, are altered in blood samples collected in the morning from patients BPD.
Thirty nine patients diagnosed as BPD according to DSM-5, and 38 healthy controls were enrolled in the study. Blood were collected at 9 AM from all subjects. Serum levels of SST, NPY, AVP, VIP and cortisol were measured.
We observed significantly lower levels of SST (p = 0.001), NPY (p = 0.001), VIP (p = 0.001) and cortisol levels (p = 0.001) in the morning in subjects with BPD compared to control subjects. Significant positive effects of Young Mania Rating Scale and lithium treatment with cortisol, SST, and VIP levels were observed.
Our study suggests that lower morning levels of SST, NPY, VIP and cortisol may represent biomarkers underlying disrupted biological rhythms and behavioral and sleep disturbances observed in patients with BPD.
People with schizophrenia are amongst the most stigmatized of those with mental illnesses. The purpose of this study was to examine whether an antistigma program which consists of education, contact, ...and viewing a film that depicts an individual with schizophrenia, can change attitudes towards people with schizophrenia. The antistigma program was carried out with first‐year medical students (n = 25). Students’ attitudes towards people with schizophrenia were assessed before and after the program. In parallel, a control group of first‐year medical students were questioned (n = 35). Assessment was repeated after 1 month. Favorable attitudinal changes were observed in terms of ‘belief about the etiology of schizophrenia’, ‘social distance to people with schizophrenia’, and ‘care and management of people with schizophrenia’. In contrast, no significant change was observed in the control group. Attitude changes tended to decrease at the 1‐month follow up. These results suggest that attitudes towards schizophrenia could be changed favorably with this program. To sustain changed attitudes towards people with schizophrenia, antistigma programs should be offered on a regular basis.